We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Blood Test Predicts Alzheimer's Risk 3.5 Years Before Clinical Diagnosis

By LabMedica International staff writers
Posted on 30 Jan 2023
Print article
Image: A blood-based test could predict onset of Alzheimer’s early in a non-invasive fashion (Photo courtesy of King’s College London)
Image: A blood-based test could predict onset of Alzheimer’s early in a non-invasive fashion (Photo courtesy of King’s College London)

A new study has found that a blood-based test can predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis. The study is based on the idea that components in the human blood are capable of modulating the formation of new brain cells, a process called neurogenesis which occurs in the hippocampus that plays a role in learning and memory. Alzheimer’s disease affects the formation of new brain cells in the hippocampus during its early stages, although previous research has managed to study neurogenesis only in its later stages by using autopsies.

Researchers at King’s College London (London, UK) set out to understand the early changes by collecting blood samples over a period of several years from 56 individuals with Mild Cognitive Impairment (MCI), a condition in which there is worsening of memory or cognitive ability. Not all individuals experiencing MCI can go on to develop Alzheimer’s disease, although those with the condition are diagnosed at a much higher rate compared to the wider population. Out of the 56 participants in the study, 36 went on to be diagnosed with Alzheimer’s disease.

In their study of how blood affected the brain cells, the researchers made a number of key discoveries. The participants from whom blood samples were collected over the years and who subsequently deteriorated and developed Alzheimer’s disease exhibited a decline in cell growth and division and a rise in apoptotic cell death (a process by which cells are programmed to die). However, the researchers found that these samples also upped the conversion of immature brain cells to hippocampal neurons.

The key reasons behind the increased neurogenesis are not yet known, although the researchers believe that it could be attributed to an early compensating mechanism for the neurodegeneration (loss of brain cells) experienced by individuals developing Alzheimer’s disease. Upon using only the blood samples collected furthest away from when the participants were diagnosed with Alzheimer’s disease, the researchers discovered that the changes in neurogenesis took place 3.5 years before a clinical diagnosis. These findings provide an opportunity to further understand the changes occurring in the brain at the earliest stages of Alzheimer’s disease, according to the researchers.

“Our findings are extremely important, potentially allowing us to predict onset of Alzheimer’s early in a non-invasive fashion,” said Dr. Edina Silajdžić, the study’s joint first author. “This could complement other blood-based biomarkers that reflect the classical signs of the disease, such as the accumulation of amyloid and tau (the ‘flagship’ proteins of Alzheimer’s disease).”

“It is now essential to validate these findings in a bigger and more diverse group of people,” added Dr. Hyunah Lee, the study’s joint first author. “We are excited about the potential applications of the blood-based test we used. For example, it can help stratify individuals with memory problems for a clinical trial of disease-modifying drugs for Alzheimer’s.”

Related Links:
King’s College London 

Gold Supplier
Syphilis Ab Assay
EIAgen Syphilis Ab Kit
Mycoplasma Pneumoniae Assay
Gold Supplier
Colon Cancer Mutation Panel
UltraSEEK Colon Panel

Print article


Clinical Chem.

view channel
Image: By analyzing urine of patients, it is possible to determine their likelihood of death (Photo courtesy of University of Liverpool)

Urine Test Accurately Predicts End of Life for Lung Cancer Patients

Lung cancer continues to be the leading cause of cancer-related deaths for both men and women around the globe. This deadly disease can affect its victims in various ways, such as through tumor growth... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more


view channel
Image: QAi Prostate is an advanced AI-powered prostate cancer diagnosis tool for pathologists (Photo courtesy of Qritive)

AI-Powered Prostate Cancer Diagnosis Tool Accurately Identifies and Classifies Tumors

Prostate adenocarcinoma is the most prevalent form of prostate cancer, representing around 90% of all prostate cases, and is also the second most commonly occurring cancer in men, demonstrating a steady... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: The Miro Canvas system is a revolutionary digital microfluidics platform that automates NGS library prep. (Photo courtesy of Miroculus)

Integra Biosciences Acquires Biotechnology Specialist Miroculus to Advance Genomics Discoveries

Next-generation sequencing (NGS) is a rapid and inexpensive approach for examining the genome - the entire set of an organism's DNA. It has gained immense popularity since its inception almost two decades... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.